News | October 29, 2007

NIH Awards Penn $2.1M for Cardiovascular Disease Management Study

October 30, 2007 – The National Institutes of Health (NIH) has awarded cardiac researchers at the University of Pennsylvania a $2.1 million grant to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.
Penn is one of eight centers throughout the United States and Canada to be a named a Clinical Coordinating Center in the National Heart Lung and Blood Institute (NHLBI)-funded Clinical Research Network. This network will fund the creation of research and clinical trials that will answer questions in cardiothoracic surgery that have eluded researchers thus far.

The eight institutions that comprise the Cardiothoracic Surgical Network will collaborate over a five-year period to improve current technologies and create new ones to treat cardiovascular disease. “The establishment of this network will result in great benefit for patients. It also encourages leaders in cardiovascular surgery to share ideas, information, data and results,” said Michael Acker, M.D., chief of Cardiovascular Surgery at the Hospital of the University of Pennsylvania, and principal investigator for the grant.

“By enhancing the ability of research teams to evaluate new techniques, technologies and devices, the network promises to improve the scientific basis of care in cardiovascular disease,” said Elizabeth G. Nabel, M.D., director of the National Heart, Lung and Blood Institute of the National Institutes of Health.

The Penn researchers will propose protocols and participate in protocol development; screen and recruit cardiac surgery for up to five randomized clinical studies in cardiac surgery; develop strategies to encourage referrals from other specialty areas; draft publications and distribute research findings; and collaborate with other centers.

The seven other heart centers participating in this landmark NIH study are: the Cleveland Clinic, Columbia University, Duke Medical Center, Emory University, Montefiore-Einstein Heart Center, University of Virginia and the Montreal Heart Institute.

For more information: www.med.upenn.edu


Additional Content

News | Cardiovascular Clinical Studies

Nov. 1, 2026 – Abbott has announced the 30-day results from the TECTONIC Coronary Artery Disease (CAD) Intravascular ...

Home November 03, 2026
Home
News | Cardiovascular Clinical Studies

Oct. 27, 2026 — Atrium Therapeutics, developer of RNA therapeutics targeted to the heart, has announced that the first ...

Home October 30, 2026
Home
News | Cardiovascular Clinical Studies

Oct. 1, 2026 — W. L. Gore & Associates’ medical business (Gore) has announced the first patient enrollment in the IBE ...

Home October 01, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 31, 2026 — Amgen has announced new findings showing Repatha (evolocumab) reduced the risk of death in high-risk ...

Home September 02, 2026
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2026 — A new study found that nearly 8 out of 10 young adult participants, average age 23 years, had ...

Home August 21, 2026
Home
Subscribe Now